Speaker Profile
Ph.D., Co-Founder & CSO, Gordian Biotechnology
Biography
Martin Borch Jensen builds systems to accelerate progress in longevity. At Gordian Biotechnology, he developed the first in vivo drug discovery platform using pooled genetic screening in patient-relevant animals, scaling testing 100x while generating systematic data on what actually works in complex biological systems. Through Norn Group, he's mobilized over $34 million in rapid research funding to bring dozens of labs into longevity, and created infrastructure for high-risk ideas that fall outside traditional funding mechanisms. His work spans new technologies, talent development, to redesigning how the field coordinates and validates progress. These efforts aim at moving longevity research from isolated breakthroughs toward industrial-scale systems with reliable measurements, focus on bottlenecks, and enabling throughput that matches the problem's urgency.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
Epigenetic Rejuvenation & Delivery for Clinical Translation
• Chair: Ryan (Yuancheng) Lu, Whitehead Institute/MIT
• David Sinclair, Harvard
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Medicine
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform/b>
• Wei-Wu He, Human Longevity
• Hussain Ahamed, Ultrahuman
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
• Michael Gurven, UC Santa Barbara
